Overview
SPECC1L-related hypertelorism syndrome, also known as Opitz BBB/G syndrome autosomal dominant (formerly classified under Orphanet code 1519), is a rare genetic condition caused by mutations in the SPECC1L gene. This syndrome is characterized by prominent facial features including hypertelorism (widely spaced eyes), which is the hallmark of the condition. It falls within the spectrum of disorders historically grouped under Opitz G/BBB syndrome, which affects multiple body systems during embryonic development. The condition primarily affects craniofacial structures, with patients commonly presenting with hypertelorism, broad nasal bridge, cleft lip and/or cleft palate, and other midline developmental defects. Additional features may include laryngotracheoesophageal abnormalities (such as laryngeal cleft or swallowing difficulties), hypospadias in males, and congenital heart defects. Intellectual development is variable, with some individuals having normal cognition while others may experience mild developmental delays. Treatment is symptomatic and supportive, tailored to the specific manifestations in each patient. Surgical correction may be required for cleft lip/palate, hypospadias, or cardiac defects. Speech therapy, feeding support, and developmental interventions may be beneficial. A multidisciplinary approach involving geneticists, craniofacial surgeons, cardiologists, urologists, and speech-language pathologists is recommended for comprehensive management. Genetic counseling is important for affected families given the autosomal dominant inheritance pattern.
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for SPECC1L-related hypertelorism syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for SPECC1L-related hypertelorism syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for SPECC1L-related hypertelorism syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to SPECC1L-related hypertelorism syndrome.
Community
No community posts yet. Be the first to share your experience with SPECC1L-related hypertelorism syndrome.
Start the conversation →Latest news about SPECC1L-related hypertelorism syndrome
No recent news articles for SPECC1L-related hypertelorism syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about SPECC1L-related hypertelorism syndrome
What is SPECC1L-related hypertelorism syndrome?
SPECC1L-related hypertelorism syndrome, also known as Opitz BBB/G syndrome autosomal dominant (formerly classified under Orphanet code 1519), is a rare genetic condition caused by mutations in the SPECC1L gene. This syndrome is characterized by prominent facial features including hypertelorism (widely spaced eyes), which is the hallmark of the condition. It falls within the spectrum of disorders historically grouped under Opitz G/BBB syndrome, which affects multiple body systems during embryonic development. The condition primarily affects craniofacial structures, with patients commonly prese
How is SPECC1L-related hypertelorism syndrome inherited?
SPECC1L-related hypertelorism syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does SPECC1L-related hypertelorism syndrome typically begin?
Typical onset of SPECC1L-related hypertelorism syndrome is neonatal. Age of onset can vary across affected individuals.